FDA considers lifting safety limits on Avandia
Monday, June 3, 2013 - 08:00
in Mathematics & Economics
WASHINGTON (AP) -- A former blockbuster diabetes pill that is subject to major safety restrictions may not be as dangerous as once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug....